BGI Genomics (300676.SZ) announced that Mr. Zhao Lijian, director and general manager of the company, and Mr. Wang Yujue, director, deputy general manager, and chief financial officer, and Ms. Xu Qian, deputy general manager and secretary of the board of directors, have implemented a shareholding plan. The plan is halfway through and they have increased their shares by 0.0753 million shares through centralized bidding on the Shenzhen Stock Exchange, accounting for 0.0181% of the company's total share capital, with a total shareholding amount of 2.6422 million yuan.
Futubull financial APP news, BGI Genomics (300676.SZ) announced that Mr. Zhao Lijian, director and general manager of the company, and Mr. Wang Yujue, director, deputy general manager, and chief financial officer, and Ms. Xu Qian, deputy general manager and secretary of the board of directors, have implemented a shareholding plan. The plan is halfway through and they have increased their shares by 0.0753 million shares through centralized bidding on the Shenzhen Stock Exchange, accounting for 0.0181% of the company's total share capital, with a total shareholding amount of 2.6422 million yuan.